Position in INO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$17,050
-$9,920 QoQ
Shares Held
15,500
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 101 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $5,988,068 across 12 Biotechnology names. INO ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,900 | $1,440,517 | |
| 2 | TECH |
BIO-TECHNE Corp
|
12,036 | $850,343 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,167 | $531,580 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
831 | $518,161 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $513,646 | |
| 6 | EXEL |
Exelixis, Inc.
|
9,079 | $493,988 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,638 | $493,087 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,954 | $387,749 |
All Filings in INO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,050 | 15,500 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $26,970 | 15,500 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $26,970 | 15,500 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $31,590 | 13,500 | Shares | Defined | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||